FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Yves Collette

Research Profile

Chemicals & Drugs

Concepts & Ideas

Living Beings

HIV-1
Mouse

Anatomy

Genes & Molecular Sequences

Amino Acid Sequences

Physiology

Co-author Network

Publications

TOP 3
Jean M Brunel; Thomas Prebet; Audrey Restouin; Chanaz Salmi-Smail; Norbert Vey; Yves Collette
Design of N-substituted amino caproic hydroxamic acid histone deacetylase inhibitors reveal an essential role for cap atomic composition.
Xiaoli Shi; Pascale Zimmermann; Sandrine Opi; Isabelle Parrot; Audrey Restouin; Stefan T Arold; Stephane Betzi; Yves Collette; Mingdong Huang; Patrick Lecine; Adrien Lugari; Jean Martinez; XAVIER MORELLI
Structural recognition mechanisms between human Src homology domain 3 (SH3) and ALG-2-interacting protein X (Alix).
Caroline Veuillen; Florence Orlanducci; Laurent Pouyet; Jérôme Rey; T Aurran-Schleinitz; Réda Bouabdallah; Xavier Carcopino; Rémy Castellano; Yves Collette; Diane Coso; Cyril Fauriat; Vadim Ivanov; Sylvaine Just-Landi; Françoise Mallet; Daniel Olive
Primary B-CLL resistance to NK cell cytotoxicity can be overcome in vitro and in vivo by priming NK cells and monoclonal antibody therapy.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Yves Collette (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Jean M Brunel; Thomas Prebet; Audrey Restouin; Chanaz Salmi-Smail; Norbert Vey; Yves Collette
Design of N-substituted amino caproic hydroxamic acid histone deacetylase inhibitors reveal an essential role for cap atomic composition.
Anti-cancer agents in medicinal chemistry 2012;12(7):801-6.
2012: Xiaoli Shi; Pascale Zimmermann; Sandrine Opi; Isabelle Parrot; Audrey Restouin; Stefan T Arold; Stephane Betzi; Yves Collette; Mingdong Huang; Patrick Lecine; Adrien Lugari; Jean Martinez; XAVIER MORELLI
Structural recognition mechanisms between human Src homology domain 3 (SH3) and ALG-2-interacting protein X (Alix).
FEBS letters 2012;586(13):1759-64.
2012: Caroline Veuillen; Florence Orlanducci; Laurent Pouyet; Jérôme Rey; T Aurran-Schleinitz; Réda Bouabdallah; Xavier Carcopino; Rémy Castellano; Yves Collette; Diane Coso; Cyril Fauriat; Vadim Ivanov; Sylvaine Just-Landi; Françoise Mallet; Daniel Olive
Primary B-CLL resistance to NK cell cytotoxicity can be overcome in vitro and in vivo by priming NK cells and monoclonal antibody therapy.
Journal of clinical immunology 2012;32(3):632-46.
2012: Julie Gertner-Dardenne; Eloïse Kochbati; Emilie Mamessier; Rémy Castellano; Aude Charbonnier; Yves Collette; Anne Etienne; Slaveia Garbit; Norbert Vey; Daniel Olive
Human Vγ9Vδ2 T cells specifically recognize and kill acute myeloid leukemic blasts.
Journal of immunology (Baltimore, Md. : 1950) 2012;188(9):4701-8.
2012: H Chaib; L Altucci; Rémy Castellano; S Garbit; A Nebbioso; T Prebet; Audrey Restouin; N Vey; Yves Collette
Anti-leukemia activity of chaetocin via death receptor-dependent apoptosis and dual modulation of the histone methyl-transferase SUV39H1.
Leukemia 2012;26(4):662-74.
2012: Lynda Mezil; Patrice Viens; Carole Berruyer-Pouyet; Daniel Birnbaum; Jean-Michel Brunel; Olivier Cabaud; Yves Collette; Sébastien Combes; Emmanuelle Josselin; Marc Lopez
Tumor selective cytotoxic action of a thiomorpholin hydroxamate inhibitor (TMI-1) in breast cancer.
PloS one 2012;7(9):e43409.
2011: Adrien Lugari; Jean Martinez; Stefan T Arold; Sebastian Breuer; Yves Collette; Thibault Coursindel; Alexis Nazabal; Sandrine Opi; Isabelle Parrot; Audrey Restouin; Xiaoli Shi; Bruce E Torbett; XAVIER MORELLI
A specific protein disorder catalyzer of HIV-1 Nef.
Bioorganic & medicinal chemistry 2011;19(24):7401-6.
2011: Hassiba Chaib; Thomas Prébet; Norbert Vey; Yves Collette
[Histone methyltransferases: a new class of therapeutic targets in cancer treatment?].
Médecine sciences : M/S 2011;27(8-9):725-32.
2010: Xiaoli Shi; Sandrine Opi; Adrien Lugari; Audrey Restouin; Thibault Coursindel; Isabelle Parrot; Javier Perez; Eric Madore; Pascale Zimmermann; Jacques Corbeil; Mingdong Huang; Stefan T Arold; Yves Collette; Xavier Morelli
Identification and biophysical assessment of the molecular recognition mechanisms between the human haemopoietic cell kinase Src homology domain 3 and ALG-2-interacting protein X.
The Biochemical journal 2010;431(1):93-102.
2010: Thibault Coursindel; Audrey Restouin; Georges Dewynter; Jean Martinez; Yves Collette; Isabelle Parrot
Stereoselective ring contraction of 2,5-diketopiperazines: An innovative approach to the synthesis of promising bioactive 5-membered scaffolds.
Bioorganic chemistry 2010;38(5):210-7.
2009: C Brignatz; M P Paronetto; Sandrine Opi; M Cappellari; Stéphane Audebert; V Feuillet; Georges Bismuth; S Roche; Stefan T Arold; C Sette; Yves Collette
Alternative splicing modulates autoinhibition and SH3 accessibility in the Src kinase Fyn.
Molecular and cellular biology 2009;29(24):6438-48.
2009: Audrey Restouin; Sandra Aresta; Thomas Prébet; Jean-Paul Borg; Ali Badache; Yves Collette
A simplified, 96-well-adapted, ATP luminescence-based motility assay.
BioTechniques 2009;47(4):871-5.
2009: Sophie Reuse; Miriam Calao; Kabamba Kabeya; Allan Guiguen; Jean-Stéphane Gatot; Vincent Quivy; Caroline Vanhulle; Aurélia Lamine; Dolores Vaira; Dominique Demonte; Valérie Martinelli; Emmanuelle Veithen; Thomas Cherrier; Véronique Avettand; Solène Poutrel; Jacques Piette; Yvan de Launoit; Michel Moutschen; Arsène Burny; Christine Rouzioux; Stéphane De Wit; Georges Herbein; Olivier Rohr; Yves Collette; Olivier Lambotte; Nathan Clumeck; Carine Van Lint
Synergistic activation of HIV-1 expression by deacetylase inhibitors and prostratin: implications for treatment of latent infection.
PloS one 2009;4(6):e6093.
2008: D Olive; J Rey; Yves Collette; X Carcopino; I Hirsch
[Pathogenic agents and cancer].
Médecine et maladies infectieuses 2008;38 Suppl 2():S45-6.
2007: Keiichiro Ohara; Michael Smietana; Audrey Restouin; Séverine Mollard; Jean-Paul Borg; Yves Collette; Jean-Jacques Vasseur
Amine-guanidine switch: a promising approach to improve DNA binding and antiproliferative activities.
Journal of medicinal chemistry 2007;50(26):6465-75.
2007: Stéphane Betzi; Audrey Restouin; Sandrine Opi; Stefan T Arold; Isabelle Parrot; Françoise Guerlesquin; XAVIER MORELLI; Yves Collette
Protein protein interaction inhibition (2P2I) combining high throughput and virtual screening: Application to the HIV-1 Nef protein.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(49):19256-61.
2006: Rémy Castellano; Bérengère Vire; Marjorie Pion; Vincent Quivy; Daniel Olive; Ivan Hirsch; Carine Van Lint; Yves Collette
Active transcription of the human FASL/CD95L/TNFSF6 promoter region in T lymphocytes involves chromatin remodeling: role of DNA methylation and protein acetylation suggest distinct mechanisms of transcriptional repression.
The Journal of biological chemistry 2006;281(21):14719-28.
2005: C Brignatz; Audrey Restouin; Grégory Bonello; Daniel Olive; Yves Collette
Evidences for ubiquitination and intracellular trafficking of LAT, the linker of activated T cells.
Biochimica et biophysica acta 2005;1746(2):108-15.
2005: Véronique Goffin; Dominique Demonté; Caroline Vanhulle; Stéphane de Walque; Yvan de Launoit; Arsène Burny; Yves Collette; Carine Van Lint
Transcription factor binding sites in the pol gene intragenic regulatory region of HIV-1 are important for virus infectivity.
Nucleic acids research 2005;33(13):4285-310.
2004: Elsa Compte; Pierre Pontarotti; Yves Collette; Marc Lopez; Daniel Olive
Frontline: Characterization of BT3 molecules belonging to the B7 family expressed on immune cells.
European journal of immunology 2004;34(8):2089-99.
2004: Grégory Bonello; Nicolas Blanchard; María C Montoya; Enrique Aguado; Claire Langlet; Hai-Tao He; Selena Nunez-Cruz; Marie Malissen; Francisco Sanchez-Madrid; Daniel Olive; Claire Hivroz; Yves Collette
Dynamic recruitment of the adaptor protein LAT: LAT exists in two distinct intracellular pools and controls its own recruitment.
Journal of cell science 2004;117(Pt 7):1009-16.
2004: Audrey Gérard; Cédric Favre; Fabien Garçon; Jean-Guy Némorin; Pascale Duplay; Sonia Pastor; Yves Collette; Daniel Olive; Jacques Nunès
Functional interaction of RasGAP-binding proteins Dok-1 and Dok-2 with the Tec protein tyrosine kinase.
Oncogene 2004;23(8):1594-8.
2003: Emmanuelle Adam; Vincent Quivy; Françoise Bex; Alain Chariot; Yves Collette; Caroline Vanhulle; Sonia Schoonbroodt; Véronique Goffin; Thi Liên-Anh Nguyên; Geoffrey Gloire; Géraldine Carrard; Bertrand Friguet; Yvan de Launoit; Arsène Burny; Vincent Bours; Jacques Piette; Carine Van Lint
Potentiation of tumor necrosis factor-induced NF-kappa B activation by deacetylase inhibitors is associated with a delayed cytoplasmic reappearance of I kappa B alpha.
Molecular and cellular biology 2003;23(17):6200-9.
2003: Yves Collette; André Gilles; Pierre Pontarotti; Daniel Olive
A co-evolution perspective of the TNFSF and TNFRSF families in the immune system.
Trends in immunology 2003;24(7):387-94.
2002: Rémy Castellano; Carine Van Lint; Valentine Peri; Emmanuelle Veithen; Yannis Morel; Regis Costello; Daniel Olive; Yves Collette
Mechanisms regulating expression of the tumor necrosis factor-related light gene. Role of calcium-signaling pathway in the transcriptional control.
The Journal of biological chemistry 2002;277(45):42841-51.
2002: Vincent Quivy; Emmanuelle Adam; Yves Collette; Dominique Demonte; Alain Chariot; Caroline Vanhulle; Ben Berkhout; Rémy Castellano; Yvan de Launoit; Arsène Burny; Jacques Piette; Vincent Bours; Carine Van Lint
Synergistic activation of human immunodeficiency virus type 1 promoter activity by NF-kappaB and inhibitors of deacetylases: potential perspectives for the development of therapeutic strategies.
Journal of virology 2002;76(21):11091-103.
2002: Vincent Feuillet; Monique Semichon; Audrey Restouin; Julie Harriague; Julia Janzen; Anthony Magee; Yves Collette; Georges Bismuth
The distinct capacity of Fyn and Lck to phosphorylate Sam68 in T cells is essentially governed by SH3/SH2-catalytic domain linker interactions.
Oncogene 2002;21(47):7205-13.
2002: C Picard; Alison L Greenway; G Holloway; Daniel Olive; Yves Collette
Interaction with simian Hck tyrosine kinase reveals convergent evolution of the Nef protein from simian and human immunodeficiency viruses despite differential molecular surface usage.
Virology 2002;295(2):320-7.
2002: Christophe Picard; André Gilles; Pierre Pontarotti; Daniel Olive; Yves Collette
Cutting edge: recruitment of the ancestral fyn gene during emergence of the adaptive immune system.
Journal of immunology (Baltimore, Md. : 1950) 2002;168(6):2595-8.
2002: María C Montoya; David Sancho; Grégory Bonello; Yves Collette; Claire Langlet; Hai-Tao He; Pedro Aparicio; Andrés Alcover; Daniel Olive; Francisco Sánchez-Madrid
Role of ICAM-3 in the initial interaction of T lymphocytes and APCs.
Nature immunology 2002;3(2):159-68.
2001: G Hassaïne; Marianne Courcoul; Gilles Bessou; Y Barthalay; C Picard; Daniel Olive; Yves Collette; Robert Vigne; jeff Keyser
The tyrosine kinase Hck is an inhibitor of HIV-1 replication counteracted by the viral vif protein.
The Journal of biological chemistry 2001;276(20):16885-93.
2000: Wen-Chin Yang; Marguerite Ghiotto; Rémy Castellano; Yves Collette; N Auphan; Jacques Nunès; Daniel Olive
Role of Tec kinase in nuclear factor of activated T cells signaling.
International immunology 2000;12(11):1547-52.
2000: Jean-Marie Péloponèse; Catherine Grégoire; Sandrine Opi; Didier Esquieu; J Sturgis; E Lebrun; E Meurs; Yves Collette; D Olive; A M Aubertin; M Witvrow; C Pannecouque; E De Clercq; Christian Bailly; Jacques Lebreton; Erwann P Loret
1H-13C nuclear magnetic resonance assignment and structural characterization of HIV-1 Tat protein.
Comptes rendus de l'Académie des sciences. Série III, Sciences de la vie 2000;323(10):883-94.
2000: Hervé Chambost; Yves Collette; H Dutartre; Isabelle Thuret; Daniel Olive
Parameters involved in the recognition of fresh human leukemic blasts by tumor-specific cytolytic T cell clones: a model study.
Leukemia research 2000;24(10):823-30.
2000: Wen-Chin Yang; Yves Collette; Jacques Nunès; Daniel Olive
Tec kinases: a family with multiple roles in immunity.
Immunity 2000;12(4):373-82.
2000: Yves Collette; Stefan T Arold; C Picard; Katy Janvier; Serge Benichou; Richard Benarous; Daniel Olive; Christian DUMAS
HIV-2 and SIV nef proteins target different Src family SH3 domains than does HIV-1 Nef because of a triple amino acid substitution.
The Journal of biological chemistry 2000;275(6):4171-6.
1999: Yves Collette; Daniel Olive
The primate lentivirus-encoded Nef protein can regulate several steps of the viral replication cycle.
Virology 1999;265(2):173-7.
1999: Alison L Greenway; H Dutartre; K Allen; Dale A McPhee; Daniel Olive; Yves Collette
Simian immunodeficiency virus and human immunodeficiency virus type 1 nef proteins show distinct patterns and mechanisms of Src kinase activation.
Journal of virology 1999;73(7):6152-8.
1999: Jean-Marie Péloponèse; Yves Collette; Catherine Grégoire; Christian Bailly; D Campèse; E F Meurs; D Olive; Erwann P Loret
Full peptide synthesis, purification, and characterization of six Tat variants. Differences observed between HIV-1 isolates from Africa and other continents.
The Journal of biological chemistry 1999;274(17):11473-8.
1999: giorgio zauli; Davide Gibellini; Paola Secchiero; H Dutartre; Daniel Olive; Silvano Capitani; Yves Collette
Human immunodeficiency virus type 1 Nef protein sensitizes CD4(+) T lymphoid cells to apoptosis via functional upregulation of the CD95/CD95 ligand pathway.
Blood 1999;93(3):1000-10.
1998: Yves Collette; A Benziane; D Razanajaona; D Olive
Distinct regulation of T-cell death by CD28 depending on both its aggregation and T-cell receptor triggering: a role for Fas-FasL.
Blood 1998;92(4):1350-63.
1998: H Dutartre; M Harris; Daniel Olive; Yves Collette
The human immunodeficiency virus type 1 Nef protein binds the Src-related tyrosine kinase Lck SH2 domain through a novel phosphotyrosine independent mechanism.
Virology 1998;247(2):200-11.
1997: Yves Collette; D Razanajaona; Marguerite Ghiotto; Daniel Olive
CD28 can promote T cell survival through a phosphatidylinositol 3-kinase-independent mechanism.
European journal of immunology 1997;27(12):3283-9.
1997: Yves Collette; H Dutartre; A Benziane; Daniel Olive
The role of HIV1 Nef in T-cell activation: Nef impairs induction of Th1 cytokines and interacts with the Src family tyrosine kinase Lck.
Research in virology 1997;148(1):52-8.
1996: Yves Collette; H Dutartre; A Benziane; Daniel Olive
Similarity between Nef of primate lentiviruses and p15E of murine and feline leukaemia viruses.
AIDS (London, England) 1996;10(4):441-2.
1996: Yves Collette; H Dutartre; Francisco Ramos-Morales; R Benarous; M Harris; Daniel Olive
Physical and functional interaction of Nef with Lck. HIV-1 Nef-induced T-cell signaling defects.
The Journal of biological chemistry 1996;271(11):6333-41.